About Us
Ainnocence is a global biotech company that leads in generative AI for therapeutic discovery, leveraging industry-grade sequence-based proprietary technology and training data from over 16 years of expertise.
Costly high-throughput wet lab screening, expensive structure biology, and inaccurate 3D modeling processes.
A radical AI drug discovery system accelerating life-saving therapies with unprecedented speed, deep virtual throughput, and higher success rates.
Our Platforms
Contact